From: Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome - where do we go from here?
PC species
Composition (% of total PC)
PC16:0/14:0
7.2
PC16:0/16:1
4.8
PC16:0/16:0
60.6
PC16:0/18:2
5.4
PC16:0/18:1
9.7
PC16:0/20:4
1.9
PC18:0/18:2
1.5
PC18:1/18:1
3.2
PC18:0/18:1
2.1